David Vanda

Imidazopyridine-based selective and multifunctional ligands of biological targets associated with psychiatric and neurodegenerative diseases.

P. Zajdel, M. Soural, David Vanda, 2019, European journal of medicinal chemistry.

New imidazopyridines with phosphodiesterase 4 and 7 inhibitory activity and their efficacy in animal models of inflammatory and autoimmune diseases.

M. Pawłowski, E. Wyska, Adam Bucki, 2020, European journal of medicinal chemistry.

1,4,6-Trisubstituted imidazo[4,5-c]pyridines as inhibitors of Bruton's tyrosine kinase.

V. Kryštof, R. Jorda, M. Soural, 2020, European journal of medicinal chemistry.

Synthesis of Novel N9-Substituted Purine Derivatives from Polymer Supported α-Amino Acids.

V. Kryštof, R. Jorda, M. Soural, 2015, ACS combinatorial science.

Novel non-sulfonamide 5-HT6 receptor partial inverse agonist in a group of imidazo[4,5-b]pyridines with cognition enhancing properties.

A. Bojarski, P. Marin, G. Satała, 2018, European journal of medicinal chemistry.

Imidazopyridine-Based 5-HT6 Receptor Neutral Antagonists: Impact of N1-Benzyl and N1-Phenylsulfonyl Fragments on Different Receptor Conformational States.

A. Bojarski, P. Marin, Rafał Kurczab, 2021, Journal of Medicinal Chemistry.